查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1566939

生物樣本庫管理系統市場：依樣本類型、按應用：2024-2033 年全球機會分析與產業預測

Biobank Management Systems Market By Sample Type , By Application : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 280 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023年生物樣本庫管理系統市場規模為21億美元，預計2033年將達46億美元，2024年至2033年複合年成長率為8.3%。

生物樣本庫管理系統是先進的平台，旨在簡化管理生物樣本和相關資料的複雜流程。這些系統可確保有效收集、儲存和搜尋對於基因組學、個人化醫療和藥物發現等各個領域的研究和開發至關重要的生物檢體。除了儲存管理之外，它還包括管理捐贈者的同意、處理資料隱私以及透過在最佳條件下儲存樣本來支援高品質研究等功能。透過自動化許多日常業務，生物樣本庫管理系統可以減少錯誤、節省時間並提高生物樣本庫效率，使研究人員和醫療相關人員能夠更輕鬆地獲得研究和臨床試驗所需的樣本。

由於研究和個人化醫療對生物樣本的需求激增，生物樣本庫數量不斷增加，這是推動全球生物樣本庫管理系統市場成長的關鍵因素。國家生物技術資訊中心 2021 年的一項研究強調了生物樣本庫活動的顯著成長，生物樣本庫的數量每年增加約 10%。隨著基因組研究的擴展，對管理和組織大量生物資料和樣本的複雜系統的需求不斷增加，進一步推動了對生物樣本庫管理系統的需求。此外，快速成長的個人化醫療需求也對市場成長做出了重大貢獻。這是因為個人化醫療嚴重依賴生物樣本的採集和分析，增加了對高效生物樣本庫管理系統的需求。 《柳葉刀》2023 年發表的一項研究預測，由於對個人化醫療和客製化治療的日益關注，生物樣本庫管理系統的採用率將增加 25%。此外，COVID-19 大流行的爆發凸顯了高效生物樣本庫系統在管理和分配研究用生物樣本方面的重要性，導致人們越來越關注生物樣本庫管理系統的採用，從而促進市場成長。此外，將人工智慧和機器學習技術整合到生物樣本庫管理系統中以增強資料分析、預測建模和自動化決策是當前的趨勢，可顯著促進市場成長。雲端基礎的生物樣本庫管理系統的採用正在興起，提供可擴展的儲存解決方案、改進的資料可存取性並增強研究團隊之間的協作。然而，對生物樣本庫管理系統的好處的認知有限以及缺乏實施和維護這些系統的專業知識正在阻礙市場的成長。儘管安全措施取得了進步，但對資料外洩和未授權存取敏感生物資料的擔憂阻礙了機構全面採用數位管理系統。相反，資料管理、自動化和雲端運算方面的技術創新正在增強生物樣本庫管理系統的能力，並有望在預測期內為全球市場擴張提供利潤豐厚的機會。此外，政府機構、研究機構和私人公司對生物銀行和相關技術的投資不斷增加，也有助於擴大生物樣本庫管理系統市場。

全球生物樣本庫管理系統產業按樣本類型、應用和區域細分。依樣本類型分為可吸收人體組織/器官樣本、植物/動物樣本和微生物樣本。依應用領域分為再生醫學、生命科學研究、臨床研究、環境研究等。從區域來看，分析包括北美、歐洲、亞太地區和拉丁美洲地區。

主要發現

從樣本類型來看，人體組織/器官樣本領域在2023年佔據市場主導地位。

依申請，2023年臨床研究板塊為大股東。

按地區分類，2023年北美佔據市場主導地位。

可以使用此報告進行客製化（需要額外費用和時間表）

  • 監管指引
  • 根據客戶興趣加入公司簡介
  • 按國家或地區進行的附加分析 – 市場規模和預測
  • 公司簡介的擴充列表
  • 歷史市場資料
  • 主要參與者的詳細資料（Excel格式，包括位置、聯絡資訊、供應商/供應商網路等）

目錄

第1章簡介

第 2 章執行摘要

第3章 市場狀況

  • 市場定義和範圍
  • 主要發現
    • 主要投資機會
    • 關鍵成功策略
  • 波特五力分析
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會

第4章生物樣本庫管理系統市場：依樣本類型

  • 市場概況
  • 可吸收人體組織器官樣本
  • 植物動物樣品
  • 微生物樣本

第5章生物樣本庫管理系統市場：依應用分類

  • 市場概況
  • 再生醫學
  • 生命科學研究
  • 臨床研究
  • 環境調查

第6章生物樣本庫管理系統市場：按地區

  • 市場概況
  • 北美洲
    • 主要市場趨勢和機遇
    • 美國生物樣本庫管理系統市場
    • 加拿大生物樣本庫管理系統市場
    • 墨西哥生物樣本庫管理系統市場
  • 歐洲
    • 主要市場趨勢和機遇
    • 德國生物樣本庫管理系統市場
    • 法國生物樣本庫管理系統市場
    • 英國生物樣本庫管理系統市場
    • 義大利生物樣本庫管理系統市場
    • 西班牙生物樣本庫管理系統市場
    • 其他歐洲國家生物樣本庫管理系統市場
  • 亞太地區
    • 主要市場趨勢和機遇
    • 日本生物樣本庫管理系統市場
    • 中國生物樣本庫管理系統市場
    • 澳洲生物樣本庫管理系統市場
    • 印度生物樣本庫管理系統市場
    • 韓國生物樣本庫管理系統市場
    • 其他亞太生物樣本庫管理系統市場
  • 拉丁美洲/中東/非洲
    • 主要市場趨勢和機遇
    • 巴西生物樣本庫管理系統市場
    • 沙烏地阿拉伯生物樣本庫管理系統市場
    • 南非生物樣本庫管理系統市場
    • 其他拉丁美洲/中東/非洲生物樣本庫管理系統市場

第7章 競爭格局

  • 介紹
  • 關鍵成功策略
  • 10家主要企業產品圖譜
  • 有競爭力的儀表板
  • 競爭熱圖
  • 主要企業定位（2023年）

第8章 公司簡介

  • Agilent Technologies, Inc.
  • CloudLIMS Technologies Pvt. Ltd.
  • AgileBio SARL
  • Modul-Bio
  • Autoscribe Informatics
  • Krishagni Solutions Pvt Ltd
  • Information Management Services, Inc
  • Technidata Inc
  • Qiagen NV
  • Azenta Inc
簡介目錄
Product Code: A323972

The biobank management systems market was valued at $2.1 billion in 2023, and is projected to reach $4.6 billion by 2033, growing at a CAGR of 8.3% from 2024 to 2033.

Biobank management system is an advanced platform designed to streamline the complex processes involved in managing biological samples and associated data. These systems ensure efficient collection, storage, and retrieval of biological specimens, which are essential for research and development in various fields, including genomics, personalized medicine, and drug discovery. In addition to storage management, these systems include features for managing consent from donors, handling data privacy, and supporting high-quality research by ensuring that samples are stored under optimal conditions. By automating many routine tasks, biobank management systems reduce errors, save time, and improve the efficiency of biobanks, making it easier for researchers and medical professionals to access the samples they need for studies and clinical trials.

Increase in number of biobanks, driven by surge in demand for biological samples in research and personalized medicine, is a significant factor fueling the growth of the global biobank management systems market. A study by the National Center for Biotechnology Information in 2021 highlighted that biobank activities have been growing significantly, with the number of biobanks increasing by approximately 10% annually. As genomic research expands, the need for sophisticated systems to manage and organize large volumes of biological data and samples has grown, further boosting the demand for biobank management systems. Moreover, surge in demand for personalized medicine is notably contributing toward the market growth. This is attributed to the fact that personalized medicine relies heavily on the availability and analysis of biological samples, increasing the need for efficient biobank management systems. A study published in The Lancet in 2023 projected a 25% rise in the adoption of biobank management systems due to the growing focus on personalized medicine and tailored treatments. Furthermore, the outbreak of the COVID-19 pandemic highlighted the importance of efficient biobanking systems to manage and distribute biological samples for research, which led to an increased focus on adopting biobank management systems, thereby augmenting the market growth. In addition, integration of AI and ML technologies in biobank management systems to enhance data analysis, predictive modeling, and automated decision-making is the current trend that is significantly augmenting the market growth. Adoption of cloud-based biobank management systems is on rise, offering scalable storage solutions, improved data accessibility, and enhanced collaboration among research teams, which is a key trend strengthening the market growth. However, limited awareness of the benefits of biobank management systems coupled with lack of expertise in implementing and maintaining these systems hinder the market growth. Despite advancements in security measures, concerns over data breaches and unauthorized access to sensitive biological data can deter institutions from fully adopting digital management systems. On the contrary, innovations in data management, automation, and cloud computing have enhanced the capabilities of biobank management systems, which are expected to offer lucrative opportunities for the expansion of the global market during the forecast period. In addition, rise in investments from government bodies, research institutions, and private companies in biobanking and related technologies are contributing to the expansion of the biobank management systems market.

The global biobank management systems industry is segmented into sample type, application, and region. By sample type, the market is divided into absorbable human tissue & organ samples, plant & animal samples, and microbial samples. On the basis of application, it is classified into regenerative medicine, life science research, clinical research, and environmental research. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By sample type, the human tissue & organ samples segment dominated the market, in terms of share, in 2023.

On the basis of application, the clinical research segment was the major shareholder in 2023.

Region wise, North America held the leading position in the market in 2023.

Competition Analysis

Competitive analysis and profiles of the major players in the global biobank management systems market include Agilent Technologies, Inc., CloudLIMS Technologies Pvt. Ltd., AgileBio SARL, Modul-Bio, Autoscribe Informatics, Krishagni Solutions Pvt Ltd., Information Management Services, Inc, Technidata Inc, Qiagen N.V, and Azenta Inc. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to sustain the intense competition and gain a strong foothold in the global market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Sample Type

  • Absorbable Human Tissue Organ Samples
  • Plant Animal Samples
  • Microbial Samples

By Application

  • Regenerative Medicine
  • Life Science Research
  • Clinical Research
  • Environmental Research

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Agilent Technologies, Inc.
    • CloudLIMS Technologies Pvt. Ltd.
    • AgileBio SARL
    • Modul-Bio
    • Autoscribe Informatics
    • Krishagni Solutions Pvt Ltd
    • Information Management Services, Inc
    • Technidata Inc
    • Qiagen N.V
    • Azenta Inc

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: BIOBANK MANAGEMENT SYSTEMS MARKET, BY SAMPLE TYPE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Sample Type
  • 4.2. Absorbable Human Tissue Organ Samples
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Plant Animal Samples
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. Microbial Samples
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country

CHAPTER 5: BIOBANK MANAGEMENT SYSTEMS MARKET, BY APPLICATION

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Application
  • 5.2. Regenerative Medicine
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Life Science Research
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Clinical Research
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country
  • 5.5. Environmental Research
    • 5.5.1. Key Market Trends, Growth Factors and Opportunities
    • 5.5.2. Market Size and Forecast, By Region
    • 5.5.3. Market Share Analysis, By Country

CHAPTER 6: BIOBANK MANAGEMENT SYSTEMS MARKET, BY REGION

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By Region
  • 6.2. North America
    • 6.2.1. Key Market Trends and Opportunities
    • 6.2.2. Market Size and Forecast, By Sample Type
    • 6.2.3. Market Size and Forecast, By Application
    • 6.2.4. Market Size and Forecast, By Country
    • 6.2.5. U.S. Biobank Management Systems Market
      • 6.2.5.1. Market Size and Forecast, By Sample Type
      • 6.2.5.2. Market Size and Forecast, By Application
    • 6.2.6. Canada Biobank Management Systems Market
      • 6.2.6.1. Market Size and Forecast, By Sample Type
      • 6.2.6.2. Market Size and Forecast, By Application
    • 6.2.7. Mexico Biobank Management Systems Market
      • 6.2.7.1. Market Size and Forecast, By Sample Type
      • 6.2.7.2. Market Size and Forecast, By Application
  • 6.3. Europe
    • 6.3.1. Key Market Trends and Opportunities
    • 6.3.2. Market Size and Forecast, By Sample Type
    • 6.3.3. Market Size and Forecast, By Application
    • 6.3.4. Market Size and Forecast, By Country
    • 6.3.5. Germany Biobank Management Systems Market
      • 6.3.5.1. Market Size and Forecast, By Sample Type
      • 6.3.5.2. Market Size and Forecast, By Application
    • 6.3.6. France Biobank Management Systems Market
      • 6.3.6.1. Market Size and Forecast, By Sample Type
      • 6.3.6.2. Market Size and Forecast, By Application
    • 6.3.7. UK Biobank Management Systems Market
      • 6.3.7.1. Market Size and Forecast, By Sample Type
      • 6.3.7.2. Market Size and Forecast, By Application
    • 6.3.8. Italy Biobank Management Systems Market
      • 6.3.8.1. Market Size and Forecast, By Sample Type
      • 6.3.8.2. Market Size and Forecast, By Application
    • 6.3.9. Spain Biobank Management Systems Market
      • 6.3.9.1. Market Size and Forecast, By Sample Type
      • 6.3.9.2. Market Size and Forecast, By Application
    • 6.3.10. Rest of Europe Biobank Management Systems Market
      • 6.3.10.1. Market Size and Forecast, By Sample Type
      • 6.3.10.2. Market Size and Forecast, By Application
  • 6.4. Asia-Pacific
    • 6.4.1. Key Market Trends and Opportunities
    • 6.4.2. Market Size and Forecast, By Sample Type
    • 6.4.3. Market Size and Forecast, By Application
    • 6.4.4. Market Size and Forecast, By Country
    • 6.4.5. Japan Biobank Management Systems Market
      • 6.4.5.1. Market Size and Forecast, By Sample Type
      • 6.4.5.2. Market Size and Forecast, By Application
    • 6.4.6. China Biobank Management Systems Market
      • 6.4.6.1. Market Size and Forecast, By Sample Type
      • 6.4.6.2. Market Size and Forecast, By Application
    • 6.4.7. Australia Biobank Management Systems Market
      • 6.4.7.1. Market Size and Forecast, By Sample Type
      • 6.4.7.2. Market Size and Forecast, By Application
    • 6.4.8. India Biobank Management Systems Market
      • 6.4.8.1. Market Size and Forecast, By Sample Type
      • 6.4.8.2. Market Size and Forecast, By Application
    • 6.4.9. South Korea Biobank Management Systems Market
      • 6.4.9.1. Market Size and Forecast, By Sample Type
      • 6.4.9.2. Market Size and Forecast, By Application
    • 6.4.10. Rest of Asia-Pacific Biobank Management Systems Market
      • 6.4.10.1. Market Size and Forecast, By Sample Type
      • 6.4.10.2. Market Size and Forecast, By Application
  • 6.5. LAMEA
    • 6.5.1. Key Market Trends and Opportunities
    • 6.5.2. Market Size and Forecast, By Sample Type
    • 6.5.3. Market Size and Forecast, By Application
    • 6.5.4. Market Size and Forecast, By Country
    • 6.5.5. Brazil Biobank Management Systems Market
      • 6.5.5.1. Market Size and Forecast, By Sample Type
      • 6.5.5.2. Market Size and Forecast, By Application
    • 6.5.6. Saudi Arabia Biobank Management Systems Market
      • 6.5.6.1. Market Size and Forecast, By Sample Type
      • 6.5.6.2. Market Size and Forecast, By Application
    • 6.5.7. South Africa Biobank Management Systems Market
      • 6.5.7.1. Market Size and Forecast, By Sample Type
      • 6.5.7.2. Market Size and Forecast, By Application
    • 6.5.8. Rest of LAMEA Biobank Management Systems Market
      • 6.5.8.1. Market Size and Forecast, By Sample Type
      • 6.5.8.2. Market Size and Forecast, By Application

CHAPTER 7: COMPETITIVE LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top Winning Strategies
  • 7.3. Product Mapping of Top 10 Player
  • 7.4. Competitive Dashboard
  • 7.5. Competitive Heatmap
  • 7.6. Top Player Positioning, 2023

CHAPTER 8: COMPANY PROFILES

  • 8.1. Agilent Technologies, Inc.
    • 8.1.1. Company Overview
    • 8.1.2. Key Executives
    • 8.1.3. Company Snapshot
    • 8.1.4. Operating Business Segments
    • 8.1.5. Product Portfolio
    • 8.1.6. Business Performance
    • 8.1.7. Key Strategic Moves and Developments
  • 8.2. CloudLIMS Technologies Pvt. Ltd.
    • 8.2.1. Company Overview
    • 8.2.2. Key Executives
    • 8.2.3. Company Snapshot
    • 8.2.4. Operating Business Segments
    • 8.2.5. Product Portfolio
    • 8.2.6. Business Performance
    • 8.2.7. Key Strategic Moves and Developments
  • 8.3. AgileBio SARL
    • 8.3.1. Company Overview
    • 8.3.2. Key Executives
    • 8.3.3. Company Snapshot
    • 8.3.4. Operating Business Segments
    • 8.3.5. Product Portfolio
    • 8.3.6. Business Performance
    • 8.3.7. Key Strategic Moves and Developments
  • 8.4. Modul-Bio
    • 8.4.1. Company Overview
    • 8.4.2. Key Executives
    • 8.4.3. Company Snapshot
    • 8.4.4. Operating Business Segments
    • 8.4.5. Product Portfolio
    • 8.4.6. Business Performance
    • 8.4.7. Key Strategic Moves and Developments
  • 8.5. Autoscribe Informatics
    • 8.5.1. Company Overview
    • 8.5.2. Key Executives
    • 8.5.3. Company Snapshot
    • 8.5.4. Operating Business Segments
    • 8.5.5. Product Portfolio
    • 8.5.6. Business Performance
    • 8.5.7. Key Strategic Moves and Developments
  • 8.6. Krishagni Solutions Pvt Ltd
    • 8.6.1. Company Overview
    • 8.6.2. Key Executives
    • 8.6.3. Company Snapshot
    • 8.6.4. Operating Business Segments
    • 8.6.5. Product Portfolio
    • 8.6.6. Business Performance
    • 8.6.7. Key Strategic Moves and Developments
  • 8.7. Information Management Services, Inc
    • 8.7.1. Company Overview
    • 8.7.2. Key Executives
    • 8.7.3. Company Snapshot
    • 8.7.4. Operating Business Segments
    • 8.7.5. Product Portfolio
    • 8.7.6. Business Performance
    • 8.7.7. Key Strategic Moves and Developments
  • 8.8. Technidata Inc
    • 8.8.1. Company Overview
    • 8.8.2. Key Executives
    • 8.8.3. Company Snapshot
    • 8.8.4. Operating Business Segments
    • 8.8.5. Product Portfolio
    • 8.8.6. Business Performance
    • 8.8.7. Key Strategic Moves and Developments
  • 8.9. Qiagen N.V
    • 8.9.1. Company Overview
    • 8.9.2. Key Executives
    • 8.9.3. Company Snapshot
    • 8.9.4. Operating Business Segments
    • 8.9.5. Product Portfolio
    • 8.9.6. Business Performance
    • 8.9.7. Key Strategic Moves and Developments
  • 8.10. Azenta Inc
    • 8.10.1. Company Overview
    • 8.10.2. Key Executives
    • 8.10.3. Company Snapshot
    • 8.10.4. Operating Business Segments
    • 8.10.5. Product Portfolio
    • 8.10.6. Business Performance
    • 8.10.7. Key Strategic Moves and Developments